Literature DB >> 12002168

Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999.

.   

Abstract

Cigarette smoking is the leading cause of preventable death in the United States and produces substantial health-related economic costs to society. This report presents the annual estimates of the disease impact of smoking in the United States during 1995-1999. CDC calculated national estimates of annual smoking-attributable mortality (SAM), years of potential life lost (YPLL), smoking-attributable medical expenditures (SAEs) for adults and infants, and productivity costs for adults. Results show that during 1995-1999, smoking caused approximately 440,000 premature deaths in the United States annually and approximately $157 billion in annual health-related economic losses. Implementation of comprehensive tobacco-control programs as recommended by CDC could effectively reduce the prevalence, disease impact, and economic costs of smoking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12002168

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  260 in total

1.  Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.

Authors:  Olivier George; Allison Lloyd; F Ivy Carroll; M Imad Damaj; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

2.  Blunted vagal reactivity predicts stress-precipitated tobacco smoking.

Authors:  Rebecca L Ashare; Rajita Sinha; Rachel Lampert; Andrea H Weinberger; George M Anderson; Meaghan E Lavery; Katherine Yanagisawa; Sherry A McKee
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

3.  Cigarette smoking and mood disorders in U.S. adolescents: sex-specific associations with symptoms, diagnoses, impairment and health services use.

Authors:  Amanda Richardson; Jian-Ping He; Laurel Curry; Kathleen Merikangas
Journal:  J Psychosom Res       Date:  2012-02-18       Impact factor: 3.006

4.  A silence that kills.

Authors:  Lyndon Haviland
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

5.  The "global settlement" with the tobacco industry: 6 years later.

Authors:  Michael Givel; Stanton A Glantz
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

6.  Courage and dignity.

Authors:  Lyndon Haviland; Cheryl G Healton; Elizabeth Fee; Theodore M Brown; Bernadette A Toomey; Beverly Kastens
Journal:  Am J Public Health       Date:  2003-07       Impact factor: 9.308

Review 7.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Smoking during teenage pregnancies: effects on behavioral problems in offspring.

Authors:  Marie D Cornelius; Lidush Goldschmidt; Natacha DeGenna; Nancy L Day
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

9.  Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States.

Authors:  Hamisu M Salihu; Muktar H Aliyu; Bosny J Pierre-Louis; Greg R Alexander
Journal:  Matern Child Health J       Date:  2003-12

10.  Predictors of smoking cessation counseling adherence in a socioeconomically disadvantaged sample of pregnant women.

Authors:  Kuang-Yi Wen; Suzanne M Miller; Amy Lazev; Zhu Fang; Enrique Hernandez
Journal:  J Health Care Poor Underserved       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.